The high cost of olaparib and the perception of new targeted drugs versus older chemotherapy can create a disconnect regarding treatment benefits.

“this is a drug that has a cost of about 12 000 a month and the reason the rhetoric and the reality are so separated is that the drugs we were using in pancreas cancer were old cytotoxic chemotherapy drugs they were drugs that were not sexy it didn't sound so great and this is a new targeted drug quote unquote targeted drug and it's based on your genomic signature which is unique to just your tumor i mean it sounds like that should be terrific the reality is the data suggests it might not be as good as if you continued that old-fashioned therapy”